Insiders · Profile

Babcock Dwight William

CEO at Perspective Therapeutics. Filing since 19 May 2008. CIK 0001359820

Company
Date
Role
Action
Shares
Amount
Of holding
12 Nov 2015
CEO
Bought
25,000
$31.74K
8.3%
9 Jun 2015
CEO
Bought
10,000
$15.30K
3.4%
3 Mar 2015
CEO
Bought
7,500
$11.33K
2.6%
2 Mar 2015
CEO
Bought
2,529
$3.82K
0.9%
1 Nov 2013
CEO
Bought
25,000
$13.25K
9.8%
21 Nov 2012
CEO
Bought
10,100
$4.04K
4.1%
19 Nov 2012
CEO
Bought
4,800
$1.78K
2.0%
16 Nov 2012
CEO
Bought
35,100
$14.79K
17.0%
22 Mar 2012
CEO
Bought
12,000
$6.31K
6.3%
20 Mar 2012
CEO
Bought
8,000
$4.00K
4.0%
21 Feb 2012
CEO
Bought
1,000
$510.00
0.5%
17 Feb 2012
CEO
Bought
10,000
$5.40K
6.5%
21 Dec 2011
CEO
Bought
20,052
$13.64K
12.1%
20 Dec 2011
CEO
Bought
19,948
$13.56K
12.8%
21 Nov 2011
CEO
Bought
3,200
$2.71K
2.0%
18 Nov 2011
CEO
Bought
1,000
$830.00
0.6%
17 Nov 2011
CEO
Bought
5,000
$3.85K
3.1%
15 Mar 2011
CEO
Bought
5,000
$5.25K
3.2%
8 Mar 2011
CEO
Bought
4,600
$5.34K
3.0%
28 Feb 2011
CEO
Bought
16,900
$21.97K
12.5%
23 Feb 2011
CEO
Bought
6,612
$8.53K
5.2%
17 Feb 2011
CEO
Bought
10,000
$5.40K
5.4%
27 Feb 2009
CEO
Bought
600
$120.00
0.5%
26 Feb 2009
CEO
Bought
47,054
$9.41K
58.4%
18 Dec 2008
Interim CEO
Bought
8,900
$2.05K
12.4%
12 Dec 2008
Interim CEO
Bought
7,300
$1.61K
11.4%
11 Dec 2008
Interim CEO
Bought
800
$168.00
1.3%
10 Dec 2008
Interim CEO
Bought
200
$42.00
0.3%
19 May 2008
Interim CEO
Bought
5,000
$4.45K
8.6%
29 decisions on file.